BridgeBio to Present Acoramidis Data on Heart Failure Events at AHA Sessions
BridgeBio says it will present new acoramidis data on heart failure events in ATTR-CM at the American Heart Association Scientific Sessions 2026.
Related stories
Bowhead Specialty Holdings Reports Quarterly Results
The headline reports results for the quarter ended September 30. The body provides no figures or further results details.
M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC
Revvity Reports Quarterly Results for Period Ended September 30
The headline provides no revenue, profit, EPS or other result figures.
M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC
Vital Farms Reports Quarterly Results for Quarter Ended September 30
M impact | EQUITY | Nov 03, 2026, 02:33 PM UTC
Xenia Hotels & Resorts Reports Quarterly Results
Xenia Hotels & Resorts reported results for the quarter ended September 30. The supplied text does not include the figures.
M impact | EQUITY | Nov 03, 2026, 02:32 PM UTC
Regal Rexnord Reports Quarterly Results Through September 30
Regal Rexnord Corporation reported results for the quarter ended September 30.
M impact | EQUITY | Nov 03, 2026, 02:32 PM UTC
Keurig Dr Pepper Reports Quarterly Results
Keurig Dr Pepper reported results for the quarter ended September 30. The supplied body contains no figures.
M impact | EQUITY | Nov 03, 2026, 02:32 PM UTC